Veness Adam M
SEC CIK 1778623 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| DNTH | Dianthus Therapeutics, Inc. /DE/ | SVP, GC, Sec | 15.0K | — | $4.63M | 5 | 2026-06-17 | 2026-08-13 |
Most active insiders at DNTH, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Garcia Marino | CEO AND Pres, Dir | — | $27.96M |
| 2 | Randhawa Simrat | EVP, Head of R, D | — | $15.00M |
| 3 | Savitz Ryan | EVP, CFO, CBO | — | $14.29M |
| 4 | CARR EDWARD | CAO | — | $5.59M |
| 5 | Veness Adam M | SVP, GC, Sec | — | $4.63M |
| 6 | Soteropoulos Paula | Dir | — | $2.25M |
| 7 | McGeorge Anne | Dir | — | $844.8K |
| 8 | Read Simon | Dir | — | $630.8K |
Transactions 5
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-08-14 16:30 | 2026-08-13 | DNTH | Dianthus Therapeutics, Inc. /DE/ | Veness Adam M | SVP, GC, Sec | M - OptEx | $18.17 | +15.0K | 15.0K | New | +$272.6K |
| DMT | 2026-08-11 17:08 | 2026-08-07+ | DNTH | Dianthus Therapeutics, Inc. /DE/ | Veness Adam M | SVP, GC, Sec | M - OptEx | $17.88 | +20.0K | 16.2K | New | +$357.6K |
| DMT | 2026-08-11 17:08 | 2026-08-07+ | DNTH | Dianthus Therapeutics, Inc. /DE/ | Veness Adam M | SVP, GC, Sec | S - Sale+OE | $110.44 | -20.0K | 0 | -100% | -$2.21M |
| DT | 2026-06-18 16:30 | 2026-06-17 | DNTH | Dianthus Therapeutics, Inc. /DE/ | Veness Adam M | SVP, GC, Sec | M - OptEx | $17.88 | +30.0K | 30.0K | New | +$536.4K |
| DMT | 2026-06-18 16:30 | 2026-06-17 | DNTH | Dianthus Therapeutics, Inc. /DE/ | Veness Adam M | SVP, GC, Sec | S - Sale+OE | $80.80 | -30.0K | 0 | -100% | -$2.42M |
Purchase Sale Sale after option exercise All abbreviations